Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow-to-Debt Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow-to-Debt Ratio of -1.15x as of September 2025, meaning its operating cash flow of $-59.35 Million could theoretically repay -1% of its total liabilities ($51.51 Million) in one year. See Eyepoint Pharmaceuticals Inc (EYPT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyepoint Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Eyepoint Pharmaceuticals Inc across 23 annual periods. Also explore EYPT shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Eyepoint Pharmaceuticals Inc (2002–2024)
Year-by-year debt coverage analysis for Eyepoint Pharmaceuticals Inc. For market capitalisation and broader financial context, see EYPT market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.54x | $-126.23 Million | $81.96 Million | ▼ -7398.5% |
| 2023 | 0.02x | $1.88 Million | $88.86 Million | ▲ +102.7% |
| 2022 | -0.77x | $-65.00 Million | $83.99 Million | ▼ -22.0% |
| 2021 | -0.63x | $-50.10 Million | $78.99 Million | ▼ -221.5% |
| 2020 | -0.20x | $-14.44 Million | $73.18 Million | ▲ +77.5% |
| 2019 | -0.88x | $-56.70 Million | $64.64 Million | ▼ -140.2% |
| 2018 | -0.37x | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.84x | $-20.49 Million | $5.34 Million | ▼ -152.5% |
| 2016 | -1.52x | $-16.32 Million | $10.74 Million | ▼ -232.8% |
| 2015 | 1.14x | $10.30 Million | $9.00 Million | ▲ +183.1% |
| 2014 | -1.38x | $-10.67 Million | $7.75 Million | ▼ -34.7% |
| 2013 | -1.02x | $-8.74 Million | $8.55 Million | ▲ +20.9% |
| 2012 | -1.29x | $-9.00 Million | $6.96 Million | ▼ -294.9% |
| 2011 | -0.33x | $-3.17 Million | $9.68 Million | ▼ -133.0% |
| 2010 | 0.99x | $9.90 Million | $9.97 Million | ▲ +259.6% |
| 2009 | -0.62x | $-8.44 Million | $13.56 Million | ▼ -110.9% |
| 2008 | -0.29x | $-5.14 Million | $17.44 Million | ▲ +71.9% |
| 2007 | -1.05x | $-21.21 Million | $20.21 Million | ▼ -104.2% |
| 2006 | -0.51x | $-16.14 Million | $31.40 Million | ▲ +91.4% |
| 2005 | -6.01x | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -6.01x | $-9.34 Million | $1.56 Million | ▼ -48.9% |
| 2003 | -4.04x | $-5.44 Million | $1.35 Million | ▲ +22.4% |
| 2002 | -5.20x | $-3.06 Million | $588.38K | — |